IGF2BP2 modulates autophagy and serves as a prognostic marker in glioma

Ning Li1,2, Limei Deng1,3, Yuming Zhang2

  • 1Department of Hematology Affiliated Hospital of Guangdong Medical University Zhanjiang Guangdong China.

Ibrain
|April 29, 2024
PubMed

Insights

Insulin-like growth factor 2 messenger RNA-binding protein 2 (IGF2BP2) promotes glioma growth and resistance to chemotherapy. Reducing IGF2BP2 levels inhibits tumor cell growth and enhances sensitivity to temozolomide, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Glioma, a malignant brain tumor, lacks effective therapeutic targets due to poorly understood development mechanisms.
  • Identifying novel molecular targets is crucial for improving glioma treatment outcomes.

Purpose of the Study:

  • To investigate the role of insulin-like growth factor 2 messenger RNA-binding protein 2 (IGF2BP2) in glioma progression.
  • To explore IGF2BP2 as a potential therapeutic target for glioma treatment.

Main Methods:

  • Analysis of The Cancer Genome Atlas (TCGA) database for IGF2BP2 expression and patient survival in low-grade glioma (LGG).
  • In vitro studies involving IGF2BP2 knockdown to assess effects on cell viability, cell cycle, colony formation, and autophagy (mCherry-GFP-LC3 assay, Western blot).
  • Immunohistochemistry to correlate IGF2BP2 and p62 expression in patient samples; drug sensitivity assays (Cell Counting Kit-8) with temozolomide.

Main Results:

  • Elevated IGF2BP2 expression correlated with shorter survival in LGG patients.
  • IGF2BP2 knockdown impaired cell viability, induced G0/G1 arrest, reduced colony formation, and increased autophagy.
  • IGF2BP2 knockdown reduced p62 levels and increased the LC3-II/LC3-I ratio, indicating enhanced autophagy.
  • Positive correlation between IGF2BP2 and p62 expression observed in glioma samples.
  • IGF2BP2 expression linked to drug resistance markers; IGF2BP2 knockdown sensitized cells to temozolomide.

Conclusions:

  • IGF2BP2 plays a significant role in glioma progression by modulating autophagy.
  • IGF2BP2 is associated with chemoresistance in glioma.
  • Targeting IGF2BP2 presents a promising strategy for enhancing glioma chemosensitization and therapy.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K